Procarbazine
In the US, Procarbazine (procarbazine systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Glioblastoma Multiforme and Hodgkin's Lymphoma.
US matches:
UK matches:
- PROCARBAZINE 50MG CAPSULES (Leaflet)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XB01
CAS registry number (Chemical Abstracts Service)
0000671-16-9
Chemical Formula
C12-H19-N3-O
Molecular Weight
221
Therapeutic Category
Cytostatic agent: Methylhydrazine derivative
Chemical Name
Benzamide, N-(1-methylethyl)-4-[(2-methylhydrazino)methyl]-
Foreign Names
- Procarbazinum (Latin)
- Procarbazin (German)
- Procarbazine (French)
- Procarbazina (Spanish)
Generic Names
- Procarbazina (OS: DCIT)
- Procarbazine (OS: BAN, DCF)
- Ibenzmethyzine (IS)
- Procarbazine Hydrochloride (OS: USAN, JAN)
- NSC 77213 (IS)
- PRO (IS)
- Ro 4-6467 (IS)
- Procarbazine Hydrochloride (PH: JP XV, Ph. Int. 4, USP 34)
- Procarbazini hydrochloridum (PH: Ph. Int. 4)
Brand Names
- Indicarb
Zydus, India - Neozine
Alkem, India - P-Carzine
Alkem, India - Matulane
Sigma Tau, United States; Sigma-Tau, Canada - Natulan
AFT, New Zealand; Link, Australia; Sigma, Netherlands; Sigma Tau, Spain; Sigma Tau, Russian Federation; sigma-tau, Switzerland; Sigma-Tau Spa, Belarus; Sigma-Tau Spa, Georgia - Procarbazine Hydrochloride Chugai
Chugai Pharmaceutical, Japan - Procarbazine
Alliance, United Kingdom; Cambridge, Malta; P & D, Malta
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
